Chroma Medicine

Cambridge, United States

Chroma Medicine is a biotechnology company that develops genetic medicines for the treatment of genetic disorders.

$135.0M raised

Feb 2023

Series B

Biotechnology Medical Therapeutics

Top Investors

ARCH Venture Partners Cormorant Asset Management Janus Henderson Investors DCVC Bio Wellington Management

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Chroma Medicine

How much funding has Chroma Medicine raised?

Chroma Medicine has raised $135.0M in total funding. The most recent round was Series B. The last funding was announced in February 2023.

Who are Chroma Medicine's investors?

Chroma Medicine's investors include ARCH Venture Partners, Cormorant Asset Management, Janus Henderson Investors, DCVC Bio, Wellington Management.

Where is Chroma Medicine headquartered?

Chroma Medicine is headquartered in Cambridge, United States.

What does Chroma Medicine do?

Chroma Medicine is a biotechnology company that develops genetic medicines for the treatment of genetic disorders.

What stage is Chroma Medicine at?

Chroma Medicine is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 28, 2023.

MLA

"Chroma Medicine — Funding & Investors." VCBacked, February 28, 2023, https://www.vcbacked.co/company/chroma-medicine. Accessed July 2, 2026.

APA

VCBacked. (2023). Chroma Medicine — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/chroma-medicine

Wikipedia (cite web)

{{cite web |title=Chroma Medicine — Funding & Investors |url=https://www.vcbacked.co/company/chroma-medicine |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 28, 2023.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K